Viking Therapeutics, Inc. (VKTX) closed at $29.73 in the latest trading session, marking a +0.61% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 0.91% for the ...
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the product, assuming it gains regulatory approval. Viking ...
Researchers at Vrak – Museum of Wrecks, in Stockholm, hope to get funds to excavate a 15th-century shipwreck from the waters ...
The Fall-Winter 2025 shows had infectious energy and eye-catching looks seen both on and off the runways. Beyond Jackson, ...
After a long period of development and having the release pushed back a couple of times, Odinfall will arrive in Early Access ...
Odinfall is a Viking-themed, rogue-lite, twin-stick shooter where you blast your way through procedurally generated levels, upgrade your character, modify your weapons and take down robotic Norse gods ...
Viking has found a manufacturing partner ... Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall. -Ciara Linnane This content was created by MarketWatch ...